Phase III trial of 5-fluorouracil and leucovorin plus either 3H1 anti-idiotype monoclonal antibody or placebo in patients with advanced colorectal cancer

Annals of Oncology - Tập 17 - Trang 437-442 - 2006
G. Chong1, A. Bhatnagar2, D. Cunningham1, T.M. Cosgriff3, P.G. Harper4, W. Steward5, J. Bridgewater6, M. Moore7, J. Cassidy8, R. Coleman9, F. Coxon10, C.H. Redfern11, J.J. Jones12, R. Hawkins13, D. Northfelt14, S. Sreedharan2, F. Valone2, J. Carmichael15
1Royal Marsden Hospital, Sutton, Surrey, UK;
2Titan Pharmaceuticals, South San Francisco, CA, USA;
3Hematology and Oncology Services, New Orleans, LA, USA;
4Guys Hospital, London, UK;
5Leicester Royal Infirmary, Leicester, UK;
6North Middlesex Hospital, Edmonton, UK;
7Georgia Cancer Research Center, Decatur, GA, USA;
8University of Aberdeen, Aberdeen, UK
9Weston Park Hospital NHS Trust, Sheffield, UK;
10Newcastle General Hospital, Newcastle-upon-Tyne, UK
11Sharp Health Care, San Diego, CA, USA
12Columbus CCOP, Columbus, OH, USA;
13Christie Hospital, Withington, UK
14University of California, San Diego, CA, USA
15City Hospital, Nottingham UK

Tài liệu tham khảo

Thông tin
Thông tin xuất bản

Annals of Oncology

Tập 17

437-442

Thông tin tác giả